Crossmark

Clinical significance and different strategies for re-elevation of plasma EBV-DNA during treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis

Crossref DOI link: https://doi.org/10.1016/j.jped.2024.03.006

Published Print: 2024-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zhang, Wenzhi http://orcid.org/0000-0003-4123-5087
Peng, Yun http://orcid.org/0009-0003-0554-0348
Qiu, Yining http://orcid.org/0009-0003-4382-3189
Cheng, Li http://orcid.org/0000-0003-4186-1651
Yin, Yuhong http://orcid.org/0009-0000-1312-4561
Li, Ying http://orcid.org/0000-0002-7665-4698
Zhao, Lizhen http://orcid.org/0009-0005-7507-1297
Wu, Xiaoyan http://orcid.org/0000-0002-1644-5325
Funding

Funding for this research was provided by:

Wuhan Municipal Science and Technology Bureau
License Information

Text and Data Mining valid from 2024-09-01

Text and Data Mining valid from 2024-09-01

Version of Record valid from 2024-04-03
More Information

This article is maintained by: Elsevier

Article Title: Clinical significance and different strategies for re-elevation of plasma EBV-DNA during treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis

Journal Title: Jornal de Pediatria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jped.2024.03.006

Content Type: article

Copyright: © 2024 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.

Document is current

Any future updates will be listed below